← Leaderboards
Jeah Jung
Pennsylvania State University, The
$5,082,234
Attributed
$5,082,234
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2010–23$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,082,234 · 4
By mechanism
R01$4,953,864 · 3
R03$128,370 · 1
Top collaborators
No co-investigators on record.
Most similar at Pennsylvania State University, The
Same institution · by research overlap
- Nina Stachenfeld$8,907,589
- Lacy M. Alexander$6,341,929
- Juliet Iwelunmor$15,013,279
- Danielle Symons Downs$4,208,344
- Andrew Patterson$11,072,873
Others in their field
Top investigators on “Caring”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$279,179,778
- Chanza Baytop · Westat, Inc.$271,217,917
- Larry Arthur$256,720,406
Research focus
CaringMedicareCostProgramsServicesOutpatientsEnsureAffectHealthcareBaseBeneficiaryEnrollmentFinancial IncentiveComplexPoliciesSamplingDiabetes MellitusRheumatoid ArthritisPatternQuality Of CareMalignant NeoplasmsResourcesDrug CostsFace
Grant awards (14)
Resource Use and Quality of Care in Medicare Advantage$639,264
R01 · FY2023 · AG · contact PI
Resource Use and Quality of Care in Medicare Advantage$422,086
R01 · FY2023 · AG · contact PI
Resource Use and Quality of Care in Medicare Advantage$627,226
R01 · FY2022 · AG · contact PI
Resource Use and Quality of Care in Medicare Advantage$544,770
R01 · FY2021 · AG · contact PI
Resource Use and Quality of Care in Medicare Advantage$484,584
R01 · FY2020 · AG · contact PI
Use of New Hepatitis C Drugs and Patients' Health Outcomes in Medicare$429,474
R01 · FY2020 · AG · contact PI
Use of New Hepatitis C Drugs and Patients' Health Outcomes in Medicare$480,581
R01 · FY2019 · AG · contact PI
Use of New Hepatitis C Drugs and Patients' Health Outcomes in Medicare$472,768
R01 · FY2018 · AG · contact PI
Use of New Hepatitis C Drugs and Patients' Health Outcomes in Medicare$70,466
R01 · FY2018 · AG · contact PI
Benefit Generosity, Specialty Drug Use, and Other Health Service Use in Medicare$240,321
R01 · FY2016 · AG · contact PI
Benefit Generosity, Specialty Drug Use, and Other Health Service Use in Medicare$262,113
R01 · FY2015 · AG · contact PI
Benefit Generosity, Specialty Drug Use, and Other Health Service Use in Medicare$280,211
R01 · FY2014 · AG · contact PI
Public Reporting and Market Area Exit Decisions by Home Health Agencies$64,455
R03 · FY2011 · AG · contact PI
Public Reporting and Market Area Exit Decisions by Home Health Agencies$63,915
R03 · FY2010 · AG · contact PI